Optimal Lymph Node Ratio Cut-Off Value for Recurrent Prognosis in Gastric Cancer: a cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250112011

Enrollment

100

Registered

2025-01-12

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer Gastric cancer

Interventions

All patients who received curative gastrectomy at Siriraj hospital during January 2016-July 2023

Diagnostic

Gastric cancer

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adenocarcinoma of stomach at Minimally Invasive Surgery Unit, Department of Surgery, Faculty of Medicine Siriraj hospital, Mahidol University, Bangkok, Thailand from January 2016 to July 2023 who underwent curative gastrectomy

Exclusion criteria

Exclusion criteria: Distant metastasis, received preoperative systemic therapy, less than 16 lymph nodes retrieval from gastrectomy operation, or had concomitant active second primary cancer

Design outcomes

Primary

Measure	Time frame
LNR at time of recurrence after surgery identify LNR to predict recurrence	—

Secondary

Measure	Time frame
Recurrence 3 years Kaplan-Meier	—

Countries

Thailand

Contacts

Public ContactChawisa Nampoolsuksan

Siriraj hospital

c.nampoolsuksan@gmail.com024198005

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026